New England Journal of Medicine Publishes Final Results from Innovative Phase 2 Study Showing Vaccines Can Reduce Rate of Sustained TB Infections in Adolescents at High Risk

ROCKVILLE, Md., July 11, 2018 /PRNewswire-USNewswire/ -- Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - 7 days ago

Share |